escitalopram / Generic mfg. 
Welcome,         Profile    Billing    Logout  
 0 Diseases   144 Trials   144 Trials   2302 News 
155 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
escitalopram / Generic mfg.
NCT00667121: Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline

Active, not recruiting
N/A
85
US
citalopram hydrobromide, escitalopram oxalate, gabapentin, sertraline hydrochloride, tamoxifen citrate, venlafaxine, molecular genetic technique, high performance liquid chromatography, laboratory biomarker analysis, pharmacological study, adjuvant therapy
Mayo Clinic, National Cancer Institute (NCI)
Breast Cancer, Depression, Hot Flashes, Psychosocial Effects of Cancer and Its Treatment
05/14
12/24
ChiCTR-TRC-14004936: Ketamine's antidepressant efficacy and safety in major depression: a randomized controlled trial

Completed
N/A
30
 
receive a single intravenous infusion of Ketamine+oral Escitalopram Oxalate Tablets 10mg/d four weeks ;receive a single intravenous infusion of 0.9% saline + +oral Escitalopram Oxalate Tablets 10mg/d four weeks
Beijing Chaoyang Hospital; Beijing Chaoyang Hospital, Ministry of Science and Technology; Beijing Municipal Administration of Hospitals
depression disorder
 
 
ChiCTR-INR-17011986: Combination of Escitalopram and antipsychotic improve negative symptoms of refractory schizophrenia

Completed
N/A
62
 
escitalopram ;placebo
Shandong Mental Health Center; Shandong Mental Health Center, personage
Refractory schizophrenia
 
 
ChiCTR-IOR-16008327: A clinical evaluation research for the treatment of major depression by integrated Disease with Zheng of TCM method

Recruiting
N/A
320
 
Escitalopram ;Escitalopram ;Liver resolve depression particles ;acupuncture
southern medical university; Guang'anmen Hospital, national sci-tech support plan
major depression disease
 
 
ChiCTR-IPR-17013173: Chinese medicine Chaihu-jia-Longgu-Muli-tang in the treatment of depression: a multi-center, randomized, open lable, controlled trial

Recruiting
N/A
150
 
Chaihu-jia-Longgu-Muli-tang ;Chai Mu jiaqiang Decoction ;Escitalopram ;Chaihu-jia-Longgu-Muli-tang+Escitalopram ;Lorazepam+Escitalopram
Nanjing University of Chinese Medicine; Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Science and technology project of Jiangsu Provincial Bureau of traditional Chinese Medicine
Depression
 
 
ChiCTR-IOR-15007551: Observe the Synchronism of Brain Network-Gene Expression in Treating Depression with Electro-acupuncture

Not yet recruiting
N/A
240
 
acupuncture and Escitalopram ;acupuncture ;Escitalopram
Peking University Sixth Hospital; Beijing University of Chinese Medicine, Natural Science Foundation of China
Depression
 
 
ChiCTR1900023492: A comparative study for the effects of escitalopram and duloxetine on anhedonia in depression

Completed
N/A
40
 
Escitalopram ;Duloxetine
ZhongDa Hospital, School of Medicine, Southeast University; ZhongDa Hospital, School of Medicine, Southeast University, Nanjing special fund for scientific and technological development
Major depressive disorder
 
 
ChiCTR1800020242: Different frequencies repetitive transcranial magnetic stimulation in combination with escitalopram in female patients with somatoform disorder: single-blind, randomised, case-controlled study

Recruiting
N/A
90
 
Escitalopram treatment ;10Hz rTMS plus Escitalopram treatment ;1Hz rTMS plus Escitalopram treatment
Affiliated mental health center, Tongji Medical College of Huazhong University of Science and Technology (HUST); Affiliated mental health center, Tongji Medical College of Huazhong University of Science and Technology (HUST), 2017 scientific study project of Health and Family Planning Commission of Wuhan Municipality
somatoform disorder
 
 
ChiCTR1900021114: A Randomized, Double Blind, Controlled Trial for the Effect of Yueju Pill in The Treatment of Patient with Depression

Recruiting
N/A
51
 
YUEJU PILL 12g/day+placebo ;YUEJU PILL 23g/day(week1)12g/day(week2-4)+placebo ;ESCITALOPRAM 10mg/day+placebo
The Fourth People's Hospital of Taizhou; Nanjing University of Traditional Chinese Medicine, Taizhou science and technology support(Social Development) plan for 2016/TS201612
Depression
 
 
ChiCTR1900026204: Canceled by the investigator. Effectiveness of rTMS in stimulating the V1 area of visual cortex versus classical target area in patients with depression: a randomized, double-blind, non-inferiority trial

Suspended
N/A
70
 
rTMS therapy (L-DLPFC)+ Escitalopram oxalate tablets (10mg/d) ;rTMS therapy (left V1 area) + Escitalopram oxalate tablets (10mg/d)
Zhongda Hospital; Zhongda Hospital, Self-financing
depression
 
 
ChiCTR2000029450: The efficacy and safety of bright light therapy combined with escitalopram oxalate in the treatment of sleep disorders associated with post-stroke depression

Recruiting
N/A
110
 
escitalopram oxalat, 10 mg,qm ;escitalopram oxalat, 10 mg,qm and BLT 30min qd
The First Affiliated Hospital of Wenzhou Medical University; The First Affiliated Hospital of Wenzhou Medical University, self-financing
Post-stroke depression
 
 
ChiCTR1800017626: A precision medicine study on the treatment of depression using Venlafaxine and Escitalopram

Recruiting
N/A
4200
 
oral administration of Venlafaxine (75-225 mg/day) ;oral administration of Escitalopram (10-20 mg/day)
Zhejiang University; The First Affliated Hospital, Zhejiang University School of Medicine, National Key Research and Development Plan, Precision Medicine Research Key Special Project
Depression
 
 
ChiCTR2000031719: Application of Objective Indicators Based on Mobile Technology in Clinical Evaluation of Depression

Recruiting
N/A
60
 
Escitalopram
Beijing Anding Hospital Affiliated to Capital Medical University; The National Clinical Research Center for Mental Disorders, Beijing Anding Hospital Capital Medical University, Beijing Municipal Administration of Hospitals' Youth Programme (QML20181904)
Major Depressive Disorder
 
 
ChiCTR2100044520: Pretest of Pharmacokinetic of Escitalopram Oxalate Tablets in healthy subjects

Recruiting
N/A
8
 
Delivery order
Dongyang Hengdian hospital; Zhejiang Baidai Pharmaceutical Technology Co., Ltd., Zhejiang Baidai Pharmaceutical Technology Co., Ltd.
Pharmacokinetic study
 
 
NCT03841474: The Recovery of Cardiovascular Patients With Depression

Recruiting
N/A
150
RoW
Psychiatric treatment with sertraline, Intervention I, Psychiatric treatment with escitalopram, Intervention II
Klinički Bolnički Centar Zagreb
Coronary Artery Disease, Depression, Cardiovascular Diseases
06/21
11/21
ChiCTR1800018063: Application of transcranial direct current stimulation in depression treatment

Not yet recruiting
N/A
160
 
Pseudo stimulus + placebo ;Pseudo stimulus + Escitalopram ;tDCS + placebo ;tACS + placebo
Shanghai Mental Health Center; Shanghai Mental Health Center, Shanghai Shenkang Hospital Development Center Clinical Science and Technology Innovation Project
depression
 
 
NCT03294525: Towards Neurobiology-based Diagnosis and Treatment of Affective Disorders

Recruiting
N/A
400
RoW
Escitalopram Pill, Lexapro, Duloxetine, Cymbalta, Mirtazapine Pill, Remeron, Other Antidepressants
Peking University
Affective Disorder
12/21
08/22
ChiCTR1900027636: A comparative study for the efficacy of group cognitive behavior therapy and SSRIs antidepressants in the treatment of depression patients with panic attack

Not yet recruiting
N/A
45
 
GCBT ;escitalopram ;GCBT+escitalopram
Peking University Sixth Hospital; Peking University Sixth Hospital, Beijing Municipal Commission of Science and Technology
Depression
 
 
ChiCTR2100041741: Efficacy of transcranial direct current stimulation (tDCS) of treating depersonalization/derealization disorder

Recruiting
N/A
80
 
F3-FP2 ;TP4-left shoulder ;Duluoxetine and escitalopram placebo ;Escitalopram and Duluoxetine placebo
Beijing Anding Hospital, Capital Medical University; Beijing Anding Hospital, Capital Medical University, Qing Miao Programme Foundation for the Talents by Beijing Hosptitals Authority
Depersonalization/realization Disorder
 
 
ChiCTR2100049747: Efficacy Observation and the Mechanism Analysis of Ningkun Jieyu Decoction in the Treatment of Major Depressive Disorder (Liver Depression and Heat) Based on the Intestinal Flora

Not yet recruiting
N/A
60
 
Granules of Ningkun Jieyu Decoction ;Escitalopram oxalate tablets (Bishike)
Xiyuan Hospital, China Academy of Chinese Medical Sciences; Xiyuan Hospital, China Academy of Chinese Medical Sciences, Qihuang Project
Major Depressive Disorder
 
 
NCT06325605: Efficacy and Safety of Bifidobacterium Combined With High-frequency Transcranial Magnetic Stimulation in the Treatment of Adolescent Depression

Completed
N/A
100
RoW
Bifidobacterium, 0.07g/capsule, approval number: Guo Yao Zhun Zi S10950032, Shanghai Sine Pharmaceutical Co., Ltd., High-frequency rTMS, Escitalopram Oxalate, manufacturer: Sichuan Kelun Pharmaceutical Co., Ltd.; approval No.: Guo Yao Zhun Zi H20080788
Zhen-Hong Hu
Adolescent Depression
10/22
10/22
ChiCTR2000036976: The exploration of the treatment mode of electroacupuncture combined with SSRI drugs for different degrees of first-onset depression

Not yet recruiting
N/A
466
 
Electroacupuncture and Escitalopram ;Sham EA and Escitalopram ;Electroacupuncture and placebo drugs ;Sham EA and Escitalopram ;Sham EA and placebo drugs
Shanghai Municipal Hospital of Traditional Chinese Medicine; Shanghai Municipal Hospital of Traditional Chinese Medicine, Government grants
Depression
 
 
ChiCTR1900027063: Comparative study on efficacy and safety of add-on sulforaphane, rTMS as antioxidant therapies for the treatment-resistant depression.

Not yet recruiting
N/A
180
 
Escitalopram 10-20mg/day, once a day, PO ;Escitalopram 10-20mg/day, once a day, PO+Sulforaphane (ZHIYINGUOSU, Shenzhen Fushan Biotech Co., Ltd.) 4~6tablets/day (be equivalent to glucosinolates 274~411 μ mol), twice a day, PO ;Escitalopram 10-20mg/day, once a day, PO+rTMS Left dorsolateral prefrontal lobe,once a day, twenty times
Shanghai Mental Health Center; Shanghai Mental Health Center, Shanghai Shenkang Hospital Development Center
Major depressive disorder
 
 
NCT02553161: Mechanism of Antidepressant-Related Dysfunctional Arousal in High-Risk Youth

Completed
N/A
214
US
Escitalopram, Lexapro, Cognitive behavioral Psychotherapy, CBT
University of Cincinnati, National Institute of Mental Health (NIMH)
Depression, Anxiety, Bipolar Disorder
07/22
12/22
NCT04977232: Adjunctive Game Intervention for Anhedonia in MDD Patients

Recruiting
N/A
50
RoW
Escitalopram, Lexapro, Game intervention
Central South University
Depression
12/22
12/22
ChiCTR1900026451: Study on Brain Network of Antidepressant Effect Mechanism with Acupuncture

Recruiting
N/A
74
 
Electroacupuncture ;Escitalopram Oxalate Tablets
Guangdong Province Traditional Chinese Medical Hospital; Sun Yat-Sen University, National Natural Science Foundation of China
Depression
 
 
ChiCTR2100045350: Effects of escitalopram on social decision-making behavior and its functional brain networks in patients with depressive disorder

Recruiting
N/A
60
 
Escitalopram ;None
Beijing Anding Hospital, Capital Medical University; Beijing Anding Hospital, Capital Medical University, Scientific Research Project of Beijing Educational Committee
Depressive disorder
 
 
ChiCTR2100047797: Effects of morinda oligosaccharides on intestinal flora and 5-HT pathway in patients with mild and moderate depression

Not yet recruiting
N/A
100
 
Morinda officinalis oligosaccharide ;Escitalopram oxalate
Beijing Anding Hospital, Capital Medical University; Beijing Anding Hospital, Capital Medical University, Beijing Anding Hospital, Capital Medical University and Institute of Toxicology and Drug, Academy of Military Medical Sciences
Major Depressive Disorder
 
 
NCT05952713: Comparative Responses to 15 Different Antidepressants in Major Depressive Disorder

Completed
N/A
73336
Europe
Antidepressant, sertraline, citalopram, fluoxetine, paroxetine, escitalopram, reboxetine, venlafaxine, duloxetine, mirtazapine, vortioxetine, agomelatine, amitriptyline, imipramine
Mental Health Services in the Capital Region, Denmark, University of Copenhagen
Major Depressive Disorder
07/23
07/23
NCT05588102: Electronic Training of Elderly Depression With Cognitive Impairment

Recruiting
N/A
128
RoW
Selective Serotonin Reuptake Inhibitor(SSRIs,Fluoxetine, paroxetine, fluvoxamine, sertraline, citalopram, escitalopram), Electronic cognitive training
Capital Medical University
Geriatric Depression, Cognitive Impairment
01/24
01/24
ChiCTR2000029000: Randomized controlled trial for clinical optimization protocol of Xing-Pi Jie-Yu Recipe in the treatment of mild to moderate depression

Not yet recruiting
N/A
130
 
Give Xingpi Jieyu Fang granules (1 dose / day, twice a day warm food) + escitalopram oxalate analog tablets 10mg / times, 1 time / d. ;Give escitalopram oxalate tablets 10mg / time, 1 time / d + Xingpi Jieyu Fang simulated granules (1 dose / day, twice a day after meal)
Dongfang Hospital of Beijing University of Chinese Medicine; Dongfang Hospital of Beijing University of Chinese Medicine, Municipal Science and Technology Funds (Research and Demonstration Application of Capital Clinical Diagnosis and Treatment Technology)
Depression
 
 
PsyCise-E, NCT05210140: Personalized Escitalopram Dosing in Patients With Depression

Recruiting
N/A
148
RoW
Escitalopram, Lexapro, Citalex
University of Belgrade, Clinical Centre of Serbia, Institute of Mental Health, Serbia, Military Medical Academy, Belgrade, Serbia
Depressive Disorder, Major
09/23
11/23
NCT05543122: Drug Concentrations in Breast Milk and Prediction of Blood Levels of the Breastfed Infants

Completed
N/A
39
Canada
either of Atenolol, Bupropion, Brivaracetam, Escitalopram, Fluconazole, Lacosamide, Lamotrigine, Levetiracetam, Methotrexate or Ezetimibe, Typical brand names include, but not limited to: Tenoretic, Wellbutrin, Zyban, Briviact, Cipralex, Lexapro, Diflucan, Vimpat, Lamictal, Keppra, Trexall, Xatmep, Ezetrol, Nexlizet
The Hospital for Sick Children, St. Justine's Hospital, University of Waterloo
Breast Feeding
12/23
03/24
ChiCTR2100054903: Study on the correlation between subjective and objective cognitive symptoms and curative effect of depression patients under the background of the construction of social psychological service system

Recruiting
N/A
200
 
Escitalopram ;None
Kangci Hospital of Jiaxing; Kangci Hospital of Jiaxing, Self-raised, Kangci Hospital of Jiaxing
Depression
 
 
ChiCTR2100043834: A controlled study of escitalopram combined with rTMS in the treatment of epileptic depression

Recruiting
N/A
94
 
Escitalopram citalopram combined with repetitive transcri magnetic stimulus ;Escitalopram citalopram
Henan Mental Health Center; The Second Affiliated Hospital of Xinxiang Medical College, Henan Mental Health Center, Qianjin Road, Xinxiang City, Henan Province, China
Epilepsy suffers from depression
 
 
LYMPHODEP, NCT06337539: Precision Psychiatry for Depression: Immune Response and Affective Symptoms as Predictors of Response to Antidepressants

Not yet recruiting
N/A
50
Europe
SSRI, Sertraline, Citalopram, Escitalopram, Fluoxetine, Paroxetine, Fluvoxamine
Germans Trias i Pujol Hospital
Depression, Inflammation, Antidepressants, Immunity
12/26
07/27
OffiGene, NCT06210321: Pharmacogenetic Testing at Community Pharmacy

Not yet recruiting
N/A
240
NA
Prescription of escitalopram using pharmacogenetic testing
Centre Hospitalier Universitaire Vaudois
Pharmacogenetic Testing
10/25
10/25
ChiCTR2300075062: Intraoperative single escitalopram ketamine vein or intranasal for cesarean delivery quality of maternal postpartum depression and postpartum recovery: a prospectie, randomized double-blind study

Not yet recruiting
N/A
150
 
Give equal intranasal saline iv + amount of saline ;Escitalopram ketamine 0.3 mg/kg intravenous(Escitalopram ketamine concentration of 2 mg/ml) + amount of intranasal saline solution ;Escitalopram intranasal ketamine 0.6 mg/kg (escitalopram ketamine concentration of 25 mg/ml) + amount of saline iv
Fuyang city people's hospital; Fuyang city people's hospital, self-raised
Cesarean delivery quality of maternal postpartum depression and postpartum recovery
 
 
NCT03511118: Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants

Recruiting
N/A
1600
Canada, US
Tranexamic acid (TXA), labetalol, metformin, nifedipine, clindamycin, oxycodone, azithromycin, escitalopram, sertraline, ondansetron, Ciprofloxacin, Doxycycline, Levofloxacin, Methylphenidate, Sumatriptan, Citalopram, Cyclobenzaprine, Furosemide, Gabapentin, Hydrochlorothiazide, Hydroxyurea, Rosuvastatin, Topiramate, Trazodone, Valganciclovir, Venlafaxine, Verapamil, Remdesivir, Anakinra, Tocilizumab, Fluvoxamine, Amoxicillin, Bupropion, Duloxetine, Hydrocodone, Levetiracetam, Paroxetine, Buprenorphine
Duke University, The Emmes Company, LLC, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Lactating Women on Select DOI, Breastfed Infants of Mothers on Select DOI
09/24
09/24
ChiCTR2300071386: Clinical study of acupuncture treatment of post-stroke depression

Recruiting
N/A
84
 
''Xingnao Kaiqiao'' acupuncture + Antidepressant acupuncture treatment ;''Xingnao Kaiqiao'' acupuncture + Escitalopram Tablets
The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine; The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, self-funded
Post-stroke depression
 
 
NCT05389046: Study on the Optimal Diagnosis and Treatment Strategy of Major Depressive Disorder Based on Anhedonia

Recruiting
N/A
252
RoW
Escitalopram, Escitalopram+Aripiprazole, Escitalopram+omega-3 PUFAs, Escitalopram+Aripiprazole+omega-3 PUFAs
Peking University
Outpatients / Inpatients With Depression
12/24
12/25
NCT04156425: The Role of PKC Activation in the Immune-inflammatory Mechanism of Major Depressive Depression

Not yet recruiting
N/A
180
NA
Escitalopram+golimumab, Lexapro+Simponi, Escitalopram+Calcium Tablet, Lexapro+Caltrate, Escitalopram, Lexapro
Shanghai Mental Health Center
Major Depressive Disorder
12/24
12/24
NCT05945342: Development and Application of Comprehensive Intervention Techniques for Adolescent Depression

Recruiting
N/A
100
RoW
Escitalopram, Interpersonal Psychotherapy for Adolescent, Escitalopram combined with psychotherapy, Escitalopram combined with rTMS, Escitalopram combined with sham rTMS
First Affiliated Hospital of Zhejiang University
Depressive Disorder, Adolescent
12/24
06/25
ChiCTR2300070111: A randomized controlled clinical study on the effect of Xingshen Jieyu Decoction on resting brain default network connection in patients with moderate post-stroke depression

Not yet recruiting
N/A
216
 
Placebo granules+escitalopram ;Xingshen Jieyu granules+escitalopram placebo ;Xingshen Jieyu granules+escitalopram ;Placebo granules+escitalopram placebo
Shanghai Seventh People's Hospital (the Seventh People's Hospital affiliated to Shanghai University of Traditional Chinese Medicine); Shanghai Seventh People's Hospital, the Clinical Research Program of Shanghai Science and Technology Committee under Grant No.21Y11921000
Moderate Poststroke depression
 
 
OPTION-VMS, NCT06049797: A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night Sweats

Recruiting
N/A
1000
US
Fezolinetant, ESN364, VEOZAH, Paroxetine, Citalopram, Escitalopram, Desvenlafaxine, Venlafaxine, Gabapentin, Clonidine, Pregabalin, Oxybutynin, Any other SSRI/SNRI not already specified, Any other non-hormonal pharmacologic therapy prescribed for the treatment of VMS not included in a category above
Astellas Pharma Global Development, Inc.
Hot Flashes
09/25
09/25
ChiCTR2300071421: Fetal microbiota transplant for additional treatment of depression: a randomized, double-blind, placebo-controlled study

Recruiting
N/A
60
 
Escitalopram+ FMT (0-2W); Escitalopram (3W-8W) ;Escitalopram+ placebo(0-2W);Escitalopram(3W-8W)
Beijing Anding Hospital Affiliated to Capital Medical University; Beijing Anding Hospital Affiliated to Capital Medical University, Beijing Science and Technology Plan
Major depressive disorder
 
 
STRATIDEP, NCT05866575: Prediction of the Therapeutic Response in Depression Based on Neuro-computational Modeling Assessment of Motivation

Not yet recruiting
N/A
136
Europe
escitalopram, vortioxetine
Centre Hospitalier St Anne
Major Depressive Disorder
11/25
12/26
ChiCTR2300067668: Study on Mechanism of Guipi Decoction in Treating Elderly Depression with Deficiency of Heart and Spleen Based on Cortical Plasticity

Not yet recruiting
N/A
99
 
Taking Guipi Decoction ;Taking escitalopram oxalate tablets ;non-intervention
The Second People's Hospital of Lishui; The Second People's Hospital of Lishui, Zhejiang Provincial Administration of Traditional Chinese Medicine
depression
 
 
ChiCTR2300073486: Transcutaneous Auricular Vagus Nerve Stimulation and Escitalopram for Major Depressive Disorder:A Double-blind, Factorial, Randomized, Controlled Clinical Trial

Not yet recruiting
N/A
448
 
taVNS + Escitalopram pills ;taVNS + placebo pills ;tnVNS+ Escitalopram pills ;tnVNS+ placebo pills
Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences; Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences, The National Key R&D Program of China(2022YFC3500501)
Major Depressive Disorder(MDD)
 
 
NCT05818735: Effect of Electroacupuncture on Treating the First-episode Depression

Recruiting
N/A
204
RoW
electroacupuncture (EA) treatment, sham acupuncture (SA) treatment, Escitalopram 10mg, real drug application, Placebo, placebo drug application
Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai Mental Health Center, Xuhui Central Hospital, Shanghai, Shanghai Huangpu District Mental Health Center
Depression
12/25
05/26
AE-TMDCS, NCT05901571: Acupuncture and Escitalopram for Treating Major Depression Clinical Study

Not yet recruiting
N/A
216
RoW
acupuncture, active acupuncture, escitalopram, sham-acupuncure, escitalopram placebo
Shanghai 7th People's Hospital
Depressive Disorder, Major
09/26
02/27
NCT03460379: Bariatric Surgery and Pharmacokinetics of Escitalopram

Recruiting
N/A
12
Europe
Escitalopram, Citalopram, Cytalopram
Norwegian University of Science and Technology, St. Olavs Hospital, Volvat Medisinsk Senter Stokkan, Namsos Hospital, Alesund Hospital
Obesity, Morbid
10/26
10/26
CLASS-BD, NCT05480150: Chinese Longitudinal and Systematic Study of Bioplar Disorder

Recruiting
N/A
10000
RoW
Escitalopram Oxalate Tablets, Lexapro, Quetiapine Fumarate Tablets, Seroquel, Lurasidone, Latuda
First Affiliated Hospital of Zhejiang University
Major Depressive Disorder, Bipolar Disorder, Mixed, Affective; Disorder, Organic
12/26
12/26
BMDD-2022, NCT06054321: Psychopharmacotherapy for Depressive Patients

Recruiting
N/A
400
RoW
stepwise pharmacotherapy, escitalopram, escitalopram with aripiprazole augmentation, escitalopram with lithium augmentation, escitalopram with mirtazapine combination, antidepressant monotherapy group, escitalopram monotherapy
Chonnam National University Hospital
Major Depressive Disorder
12/28
12/30
ACTRN12609000011280: Sub-chronic administration of the selective serotonin reuptake inhibitor escitalopram in healthy volunteers: drug initiation effects and the role of serotonin in experimental anxiety.

Recruiting
N/A
28
 
University of Western Australia, University of Western Australia Small Grants Scheme 2007
anxiety, selective serotonin reuptake inhibitor (SSRI) initiation effects
 
 
 

Download Options